# US 2001/0022964 A1 · Fast dissolving orally consumable films

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0022964 A1
- Document ID: US20010022964A1
- Status: Published application
- Kind: A1
- Application number: 09/836,474
- Filed: 2001-04-18
- Published: 2001-09-20
- Earliest claimed: 1998-09-25
- Assignees: Warner-Lambert Company
- Inventors: Sau-Hung S. Leung; Robert S. Leone; Lori D. Kumar; Neema Kulkarni; Albert F. Sorg
- Web page: https://patentgrep.com/patent/US20010022964A1

## CPC

- A23G 3/50: characterised by shape, structure or physical form, e.g. products with supported structure
- A61K 8/0208: {Tissues; Wipes; Patches}
- A61K 8/0216: {Solid or semisolid forms}
- A61K 8/21: Fluorides; Derivatives thereof
- A61K 8/34: Alcohols
- A61K 8/347: {Phenols}
- A61K 8/37: Esters of carboxylic acids
- A61K 8/416: {Quaternary ammonium compounds (A61K8/35 takes precedence)}
- A61K 8/43: Guanidines
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/4973: {with oxygen as the only hetero atom}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/645: {Proteins of vegetable origin; Derivatives or degradation products thereof}
- A61K 8/65: Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
- A61K 8/73: Polysaccharides
- A61K 8/731: {Cellulose; Quaternized cellulose derivatives}
- A61K 8/732: {Starch; Amylose; Amylopectin; Derivatives thereof}
- A61K 8/733: {Alginic acid; Salts thereof}
- A61K 8/736: {Chitin; Chitosan; Derivatives thereof}
- A61K 8/8129: {Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether}
- A61K 8/8147: {Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers}
- A61K 8/8152: {Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers}
- A61K 8/8176: {Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers}
- A61K 8/86: Polyethers
- A61K 8/922: {of vegetable origin}
- A61K 9/0056: {Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals}
- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K 31/00: Medicinal preparations containing organic active ingredients
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/12: Antidiarrhoeals
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/10: Expectorants
- A61P 11/14: Antitussive agents
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61Q 11/00: Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
- A61K 9/2072: {characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms (A61K9/0004, A61K9/0056, A61K9/0065 take precedence)}
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Physiologically acceptable films, including edible films, are disclosed. The films include a water soluble film-forming polymer such as pullulan. Edible films are disclosed that include pullulan and antimicrobially effective amounts of the essential oils thymol, methyl salicylate, eucalyptol and menthol. The edible films are effective at killing the plaque-producing germs that cause dental plaque, gingivitis and bad breath. The film can also contain pharmaceutically active agents. Methods for producing the films are also disclosed.

## Claims

### Claim 1

A consumable film adapted to adhere to and dissolve in a mouth of a consumer, wherein said film comprises at least one water soluble polymer and an antimicrobial effective amount of at least one essential oil selected from the group consisting of thymol, methyl salicylate, eucalyptol and menthol.

### Claim 2 (depends on 1)

The consumable film according to claim 1, comprising at least two of said essential oils.

### Claim 3 (depends on 1)

The consumable film according to claim 1, comprising at least three of said essential oils.

### Claim 4 (depends on 1)

The consumable film according to according to claim 1, comprising thymol, methyl salicylate, eucalyptol and menthol.

### Claim 5 (depends on 4)

The consumable film according to claim 4, further comprising a salt or gluconic acid.

### Claim 6 (depends on 4)

The consumable film according to claim 4, further comprising copper gluconate.

### Claim 7 (depends on 1)

The consumable film according to claim 1, wherein said water soluble polymer is selected from the group consisting of pullulan, hydroxyproplymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein and mixtures thereof.

### Claim 8 (depends on 7)

The consumable film according to claim 7, wherein said water soluble polymer is pullulan.

### Claim 9 (depends on 8)

The consumable film of claim 8, comprising:
about 40 to about 80 wt % pullulan;
about 0.01 to about 4 wt % thymol;
about 0.01 to about 4 wt % methyl salicylate;
about 0.01 to about 4 wt % eucalyptol; and
about 0.01 to about 15 wt % menthol.

### Claim 10 (depends on 7)

The consumable film according to claim 7, further comprising:
about 0.01 to about 5 wt % of at least one stabilizing agent;
about 0.001 to about 0.1 wt % of at least one of at least one coloring agent;
about 0.1 to about 8 wt % of water;
about 0.1 to about 15 wt % of at least one sweetening agent;
about 0.1 to about 15wt % of at least one flavoring agent;
about 0.1 to about 4 wt % of at least one cooling agent; and
about 0.1 to about 5 wt % of at least one surfactant.

### Claim 11 (depends on 10)

The consumable film according to according to claim 10, wherein said least one stabilizing agent is selected from the group consisting of xanthan gum, locust bean gum and carrageenan, and said at least one sweetening agent is selected from the group consisting of saccharin, aspartame and acesulfame K.

### Claim 12 (depends on 1)

The consumable film according to claim 1, wherein said film does not substantially adhere to itself.

### Claim 13 (depends on 1)

The consumable film according to claim 1, wherein said film is free of glycerin and sorbitol.

### Claim 14 (depends on 1)

The consumable film according to claim 1, wherein said film is free of humectants.

### Claim 15 (depends on 1)

The consumable film according to claim 1, wherein the essential oils comprises at least about 10 wt % of the film.

### Claim 16 (depends on 15)

The consumable film according to claim 15, wherein the essential oils comprises at least about 15 wt % of the film.

### Claim 17 (depends on 1)

The consumable film according to claim 1, further comprising water in an amount from about 3 wt % to about 8 wt %.

### Claim 18

A method for preparing a physiologically compatible film, said method comprising:
mixing at least one water soluble film former and at least one stabilizing agent to provide a film-forming mixture;
dissolving water-soluble ingredients in water to provide an aqueous solution;
combining said film-forming mixture and said aqueous solution to provide a hydrated polymer gel;
mixing oils to form an oil mixture;
adding said oil mixture to said hydrated polymer gel and mixing to provide a uniform gel;
casting the uniform gel on a substrate; and
drying the cast gel to provide said film.

### Claim 19 (depends on 18)

The method according to claim 18, wherein at least one surfactant is mixed into said oil mixture.

### Claim 20 (depends on 18)

The method according to claim 18, wherein the total amount of said oils in said oil mixture is at least about 5 wt % of the total weight of ingredients in said method.

### Claim 21 (depends on 20)

The method according to claim 20, wherein said total amount of oils is at least about 15 wt %.

### Claim 22 (depends on 18)

The method according to claim 18, wherein said drying is conducted until said film has a moisture content of about 3 wt % to about 8 wt %.

### Claim 23 (depends on 18)

The method according to claim 18, wherein, prior to being combined with said aqueous solution, said film-forming mixture is hydrated with water at a temperature of about 25 to about 50° C. and subsequently chilled to a temperature of about 4 to about 30° C. for about 2 to 48 hours.

### Claim 24 (depends on 18)

The method according to claim 18, wherein said film-forming mixture is a powder, which is directly combined with said aqueous solution.

### Claim 25 (depends on 24)

The method according to claim 24, wherein said hydrated polymer gel is formed without heating.

### Claim 26 (depends on 25)

The method according to claim 25, wherein said hydrated polymer gel is stirred at room temperature for about 2 to about 48 hours.

### Claim 27 (depends on 26)

The method according to claim 26, wherein said oil mixture is prepared by mixing thymol and menthol in a flavor oil, and subsequently adding methyl salicylate and eucalyptol.

### Claim 28 (depends on 18)

A non-self-adhering film produced according to the method of claim 18.

### Claim 29 (depends on 18)

The method according to claim 18, wherein the water soluble film former is selected from the group consisting of pullulan, hydroxyproplymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein and mixtures thereof.

### Claim 30 (depends on 29)

The method according to claim 29, wherein said water soluble polymer is pullulan.

### Claim 31

A consumable film adapted to dissolve in the mouth of a consumer, wherein said film comprises a single layer including pullulan and at least one pharmaceutical agent.

### Claim 32 (depends on 31)

The consumable film according to claim 31, wherein said pharmaceutical agent is selected from the group consisting of antimicrobial agents, non-steroidal anti-inflammatory agents, anti-tussives, decongestants, anti-histamines, expectorants, anti-diaherrals, H2-antagonists, proton pump inhibitors, central nervous system agents, analgesics. and mixtures thereof.

### Claim 33 (depends on 32)

The consumable film according to claim 32, wherein the antimicrobial agent is selected from the group consisting of triclosan, cetyl pyridium chloride, domiphen bromide, quaternary ammonium salts, zinc compounds, sanguinarine, fluorides, alexidine, octonidine, EDTA and mixtures thereof.

### Claim 34 (depends on 32)

The consumable film according to claim 32, wherein the non-steroidal anti-inflammatory agent is selected from the group consisting of aspirin, acetaminophen, ibuprofen, diflunisal, fenoprofen calcium, naproxen, tolmetin sodium, indomethacin, and mixtures thereof.

### Claim 35 (depends on 32)

The consumable film according to claim 32, wherein the anti-tussive is selected from the group consisting of benzonatate, caramiphen edisylate, dextromethorphan hydrobromide, chlophedianol hydrochloride and mixtures thereof.

### Claim 36 (depends on 32)

The consumable film according to claim 32, wherein the decongestant is selected from the group consisting of pseudoephedrine hydrochloride, phenylepherine, phenylpropanolamine and mixtures thereof.

### Claim 37 (depends on 32)

The consumable film according to claim 32, wherein the anti-histamine is selected from the group consisting of brompheniramine maleate, chlorpheniramine maleate, carbinoxamine maleate, clemastine fumarate, dexchlorpheniramine maleate, diphenhydramine hydrochloride, diphenhydramine citrate, diphenylpyraline hydrochloride, doxylamine succinate, promethazine hydrochloride, pyrilamine maleate, tripelennamine citrate, triprolidine hydrochloride and mixtures thereof.

### Claim 38 (depends on 32)

The consumable film according to claim 32, wherein the expectorant is selected from the group consisting of guaifenesin, ipecac, potassium iodide, terpin hydrate and mixtures thereof.

### Claim 39 (depends on 32)

The consumable film according to claim 32, wherein the anti-diarrheal is loperamide.

### Claim 40 (depends on 32)

The consumable film according to claim 32, wherein the H2-antagonist is selected from the group consisting of famotidine, ranitidine and mixtures thereof.

### Claim 41 (depends on 32)

The consumable film according to claim 32, wherein the proton pump inhibitor is selected from the group consisting of omeprazole, lansoprazole, and mixtures thereof.

### Claim 42

A method for delivering and enhancing the retention of an effective amount of an antimicrobial agent to the oral cavity comprising introducing in the oral cavity a rapidly dissolving film comprising pullulan and an antimicrobial agent comprising menthol and at least one of methyl salicylate, eucalyptol and thymol, wherein said pullulan enhances the retention of the antimicrobial agent in the oral cavity.

### Claim 43 (depends on 42)

The method according to claim 42, wherein the antimicrobial agent comprises menthol, methyl salicylate, eucalyptol and thymol.

### Claim 44 (depends on 42)

The method according to claim 42, wherein the amount of pullulan in the film is from about 40 wt % to about 80 wt %.

### Claim 45 (depends on 42)

The method according to claim 42, wherein the amount of antimicrobial agent in the film is from about 5 wt % to about 12 wt %.

### Claim 46 (depends on 43)

The method according to claim 43, wherein the amount of antimicrobial agent in the film is from about 5 wt % to about 12 wt %.

### Claim 47 (depends on 9)

A method for delivering and enhancing the retention of an effective amount of an antimicrobial agent to the oral cavity comprising introducing in the oral cavity the consumable film according to claim 9.
